Skip to main content

ENDRA Life Sciences Inc.

NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001681682

No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by ENDRA Life Sciences Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for ENDRA Life Sciences Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for ENDRA Life Sciences Inc.
NameTitleLast reported holdingLast filingFilings, past year
Tokman Alexander YChief Executive Officer101,926Mar 4, 20262
Jacroux RichardChief Financial Officer33,461Mar 4, 20262
Digiandomenico AnthonyDirector136,589Jan 23, 20262
Harsh MichaelDirector65,710Jan 23, 20261
Basenese LouDirector65,709Jan 23, 20261
UBS Group AGOther: Market maker/broker-dealer146,012IndirectSep 5, 20240
Thornton Michael MilosChief Technology Officer34,139May 22, 20230
Michelon Francois RogerChief Executive Officer97,191Feb 1, 20230
Pestrikova IrinaSenior Director, Finance–Feb 1, 20230
Maloberti Renaud BertrandChief Commercial Officer–Mar 30, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 5, 2024 (view filing)Aug 279 daysUBS Group AGOther: Market maker/broker-dealerPPurchase0–$00.0%146.0K afterAmended
May 22, 2023 (view filing)May 184 daysThornton Michael MilosChief Technology OfficerPPurchase+15.0K$1.65+$24.8K+78.4%34.1K after
May 3, 2023 (view filing)4:07 PM ETMay 21 dayDigiandomenico AnthonyDirectorPPurchase+83.3K$1.20+$100.0K+436.3%102.4K after
May 3, 2023 (view filing)4:07 PM ETMay 21 dayDigiandomenico AnthonyDirectorPPurchase+41.7K$0.01+$416.67–41.7K afterDerivative
Dec 13, 2022 (view filing)Dec 94 daysThornton Michael MilosChief Technology OfficerPPurchase+1.50K$3.40+$5.10K+8.5%19.1K after
Nov 28, 2022 (view filing)5:00 PM ETNov 235 daysTokman Alexander YDirectorPPurchase+10.0K$0.17+$1.70K+6.5%162.9K after
Aug 24, 2022 (view filing)8:57 AM ETAug 222 daysThornton Michael MilosChief Technology OfficerPPurchase+20.0K$0.27+$5.40K+6.0%352.8K after
Aug 24, 2022 (view filing)8:55 AM ETAug 222 daysTokman Alexander YDirectorPPurchase+20.0K$0.26+$5.20K+15.1%152.9K after
May 31, 2022 (view filing)8:46 AM ETMay 265 daysThornton Michael MilosChief Technology OfficerPPurchase+25.0K$0.21+$5.25K+8.1%332.8K after
May 23, 2022 (view filing)4:30 PM ETMay 185 daysLateThornton Michael MilosChief Technology OfficerPPurchase+25.0K$0.22+$5.50K+8.8%307.8K after
May 19, 2022 (view filing)7:00 AM ETMay 172 daysMichelon Francois RogerChief Executive OfficerPPurchase+5.10K$0.19+$969+5.5%97.2K after
May 17, 2022 (view filing)4:14 PM ETMay 161 dayTokman Alexander YDirectorPPurchase+100.0K$0.1963+$19.6K+304.3%132.9K after
Aug 27, 2021 (view filing)Aug 25-262 daysBasenese LouDirectorSSale−50.0K$1.83−$91.6K−50.5%49.1K after2 lots